Monoclonal Antibodies: Stanford Academia-Industry Collaboration
Uploaded by: stanforduniversity
Video Description:
August 22, 2007 presentation by Ron Levy for the Stanford School of Medicine Medcast lecture series.
Ron Levy, MD, professor of Medicine at Stanford, recounts his experiences moving his discovery from the lab to the clinical setting and discusses the future of this cancer treatment. Wendy Harpham, a participant in the early clinical trials of Rituxan, the first FDA-approved monoclonal antibody for cancer treatment that Levy developed, provides a patient's perspective.
Stanford University School of Medicine:
http://med.stanford.edu/
Stanford University Channel on YouTube:
http://www.youtube.com/stanforduniversity
Tags for this video: antibody autoimmune cancer chemoth colon disease health immune infectious lymph lymphoma medicine monoclonal multiple node personalized rejection remission research sclerosis system therapy translational transplant treatment tumor
Find more videos in the "Education" category
See more videos uploaded by stanforduniversity
| Optical Antigen-Antibody Reaction Measurement Instrument | Is Evidence-Based Medicine a Barrier to Cost-Effective Care? | Lecture 1 | Programming Abstractions (Stanford) |
 |  |  |
| Stem Cells: Regeneration Cancer and Natural Selection | Davos Annual Meeting 2008 - Benjamin Zander | Maternal Infant Care and Challenges in East Africa |
 |  |  |
Share This Video:
Comments for this video: Show || Hide
| Comments for this video on YouTube |
Tell a friend: